Cargando…
Chemoradiation for oesophageal cancer: the choice of treatment modality
BACKGROUND: Locally advanced oesophageal cancer can be treated with definitive chemoradiation (dCRT) or with neoadjuvant chemoradiation followed by surgery (nCRT + S), but treatment modality choice is not always clear. The aim of this study was to investigate the factors associated with the choice o...
Autores principales: | Kitti, Pauliina M., Faltinova, Maria, Kauppi, Juha, Räsänen, Jari, Saarto, Tiina, Seppälä, Tiina, Anttonen, Anu M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230716/ https://www.ncbi.nlm.nih.gov/pubmed/37259100 http://dx.doi.org/10.1186/s13014-023-02290-9 |
Ejemplares similares
-
Combined modality chemoradiation in elderly oesophageal cancer patients
por: Anderson, S E, et al.
Publicado: (2007) -
Effect of palliative care decisions making on hospital service use at end-of-life in patients with malignant brain tumors: a retrospective study
por: Nåhls, Nelli-Sofia, et al.
Publicado: (2023) -
Palliative intensity modulated radiotherapy of bone metastases based on diagnostic instead of planning computed tomography scans
por: Larjavaara, Suvi, et al.
Publicado: (2023) -
Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study
por: Järvinen, Tommi, et al.
Publicado: (2018) -
Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)